Siegfried Wurster
Directeur Technique/Scientifique/R&D chez Karyon-CTT Oy
Profil
Siegfried Wurster is Chief Scientific Officer of Karyon-CTT Oy.
Prior to joining Karyon in 2006 he was Director of Sciences at Juvantia Pharma Ltd.
Dr. Wurster holds a PhD in Chemistry from the University of Freiburg.
Postes actifs de Siegfried Wurster
| Sociétés | Poste | Début |
|---|---|---|
Karyon-CTT Oy
 Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Directeur Technique/Scientifique/R&D | 01/01/2006 |
Anciens postes connus de Siegfried Wurster
| Sociétés | Poste | Fin |
|---|---|---|
Juvantia Pharma Oy
 Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Directeur Technique/Scientifique/R&D | - |
Formation de Siegfried Wurster
| University of Freiburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Juvantia Pharma Oy
Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Commercial Services |
Karyon-CTT Oy
Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Commercial Services |
